All Stories

  1. User acceptability profiles of vaginal treatments among women with genitourinary syndrome of menopause

    Article • PLOS One, September 2025, PLOS

    Prof Dr Hasniza Zaman Huri

  2. Drug-related problems in patients with rheumatoid arthritis

    Article • Therapeutics and Clinical Risk Management, March 2019, Dove Medical Press

    Prof Dr Hasniza Zaman Huri, Fariz Yahya

  3. Effectiveness of the prescribed lipid-lowering therapy for diabetic patients

    Article • Therapeutics and Clinical Risk Management, January 2019, Dove Medical Press

    Prof Dr Hasniza Zaman Huri, Mohamed Hassan Elnaem

  4. The Use of Antidepressants for Physical and Psychological Symptoms in Cancer

    Article • Current Drug Targets, July 2018, Bentham Science Publishers

    Prof Dr Hasniza Zaman Huri, Nor Zuraida Zainal, Syahrir Zaini

  5. Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer

    Article • Current Pharmaceutical Design, September 2017, Bentham Science Publishers

    Prof Dr Hasniza Zaman Huri, riyanto widodo

  6. Drug-related problems in patients with erectile dysfunctions and multiple comorbidities

    Article • Therapeutics and Clinical Risk Management, March 2017, Dove Medical Press

    Prof Dr Hasniza Zaman Huri

  7. Apoptotic induction and inhibition of NF-κB signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2'-oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis: an in vitro study

    Article • OncoTargets and Therapy, January 2017, Dove Medical Press

    Swee Keong Yeap, Prof Dr Hasniza Zaman Huri

  8. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells

    Article • Drug Design Development and Therapy, August 2016, Dove Medical Press

    Prof Dr Hasniza Zaman Huri

  9. Association of psychological factors, patients’ knowledge, and management among patients with erectile dysfunction

    Article • Patient Preference and Adherence, May 2016, Dove Medical Press

    Prof Dr Hasniza Zaman Huri

  10. Glycaemic control and antidiabetic drugs

    Article • Drug Design Development and Therapy, August 2015, Dove Medical Press

    Miss Lim Lay Peng, Dr Soo Kun Lim , Prof Dr Hasniza Zaman Huri

  11. Glycemic control and cardiovascular complications

    Article • Drug Design Development and Therapy, August 2015, Dove Medical Press

    Prof Dr Hasniza Zaman Huri, Miss Doris Ling Yew Hui

  12. Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells

    Article • Molecules, May 2015, MDPI AG

    Dr Mohamad Hafizi Abu Bakar , Prof Dr Hasniza Zaman Huri

  13. Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes

    Article • Molecular BioSystems, January 2015, Royal Society of Chemistry

    Dr Mohamad Hafizi Abu Bakar , Prof Dr Hasniza Zaman Huri

  14. Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review

    Article • Global Journal of Health Science, January 2015, Canadian Center of Science and Education

    Prof Dr Hasniza Zaman Huri

  15. Amelioration of Mitochondrial Dysfunction-Induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-κB Pathways

    Article • International Journal of Molecular Sciences, December 2014, MDPI AG

    Dr Mohamad Hafizi Abu Bakar , Prof Dr Hasniza Zaman Huri

  16. Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids

    Article • Diabetes/Metabolism Research and Reviews, October 2014, Wiley

    Dr Mohamad Hafizi Abu Bakar , Prof Dr Hasniza Zaman Huri

  17. Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study

    Article • PLOS One, September 2014, PLOS

    Prof Dr Hasniza Zaman Huri

  18. Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study

    Article • BMJ Open, July 2014, BMJ

    Prof Dr Hasniza Zaman Huri

  19. Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes

    Article • Pharmacogenomics, February 2014, Future Medicine

    Prof Dr Hasniza Zaman Huri, PROFESSOR DR NORLAILA MUSTAFA

  20. Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study

    Article • PLOS One, January 2014, PLOS

    Prof Dr Hasniza Zaman Huri

  21. Occupational health risk of Pharmaceutical workers

    Article • Journal of Occupational Health, January 2014, Japan Society for Occupational Health

    Prof Dr Hasniza Zaman Huri, Professor Md. Moklesur Rahman Rahman Sarker

  22. Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study

    Article • International Journal of Endocrinology, January 2014, Hindawi Publishing Corporation

    Prof Dr Hasniza Zaman Huri

  23. Palm Olein as Renewable Raw Materials for Industrial and Pharmaceutical Products Applications: Chemical Characterization and Physicochemical Properties Studies

    Article • Advances in Materials Science and Engineering, January 2014, Hindawi Publishing Corporation

    Prof Dr Hasniza Zaman Huri

  24. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia

    Article • BMC Public Health, December 2013, Springer Science + Business Media

    Prof Dr Hasniza Zaman Huri

  25. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study

    Article • BMC Endocrine Disorders, January 2013, Springer Science + Business Media

    Prof Dr Hasniza Zaman Huri

  26. Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease

    Article • International Journal of Endocrinology, January 2013, Hindawi Publishing Corporation

    Prof Dr Hasniza Zaman Huri

  27. Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus

    Article • International Journal of Clinical Pharmacy, August 2012, Springer Science + Business Media

    Prof Dr Hasniza Zaman Huri, PROFESSOR DR NORLAILA MUSTAFA

  28. Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease

    Article • February 2012, IntechOpen

    Prof Dr Hasniza Zaman Huri

  29. Use of Antiplatelet Agents for Primary and Secondary Prevention of Cardiovascular Disease Amongst Type 2 Diabetic Patients

    Article • Journal of Pharmacy Practice, July 2008, SAGE Publications

    Prof Dr Hasniza Zaman Huri